Maternal serum screening in triploidy [2]

Prenatal Diagnosis

Volumn 22, Issue 12, 2002, Pages 1113-1114

  McFadden, Deborah E ^a   Hulait, Gurdip ^a   Lockitch, Gillian ^a   Langlois, Sylvie ^a  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; BLOOD; FEMALE; FETOMATERNAL TRANSFUSION; FETUS DISEASE; GENETICS; HUMAN; LETTER; MASS SCREENING; METHODOLOGY; PHENOTYPE; POLYPLOIDY; PREGNANCY; PRENATAL DIAGNOSIS; SEX CHROMOSOME ABERRATION; X CHROMOSOME; DISEASE ASSOCIATION; DISEASE MARKER; GENOME; HISTOPATHOLOGY; INTRAUTERINE GROWTH RETARDATION; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; TRIPLOIDY;

ADULT; BIOLOGICAL MARKERS; CHROMOSOMES, HUMAN, X; FEMALE; FETAL DISEASES; HUMANS; MASS SCREENING; MATERNAL-FETAL EXCHANGE; PHENOTYPE; POLYPLOIDY; PREGNANCY; PRENATAL DIAGNOSIS; SEX CHROMOSOME ABERRATIONS;

EID: 0036898403     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.477     Document Type: Letter

References (15)

1. Benn PA, Gainey A, Ingardia CJ, Rodis JF, Egan JFX. 2001. Second trimester maternal serum analytes in triploid pregnancies: Correlation with phenotype and sex chromosome complement. Prenat Diagn 21: 680-686.
2. Daniel A, Wu Z, Bennetts B, et al. 2001. Karyotype, phenotype and parental origin in 19 cases of triploidy. Prenat Diagn 21: 1034-1048.
3. Fejgin M, Amiel A, Kohn G. 1993. More about low maternal serum human chorionic gonadotropin and unconjugated estriol levels in triploidy. Am J Obstet Gynecol 168: 1641.
4. Freeman SB, Priest JH, MacMahon WC, Fernhoff PM, Elsas LJ. 1989. Prenatal ascertainment of triploidy by maternal serum alpha-fetoprotein screening. Prenat Diagn 9: 339-347.
5. Goshen R, Gonik B, de-Groot N, Hochberg AA. 1994. The genomic basis of the beta-subunit of human chorionic gonadotropin diversity in triploidy. Am J Obstet Gynecol 170: 700.
6. Haig D. 1993. Genomic imprinting, human chorionic gonadotropin, and triploidy. Prenat Diagn 13: 151.
7. Harper MA, Ruiz C, Pettenati MJ, Rao PN. 1994. Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and hCG screening. Obstet Gynecol 83: 844-846.
8. Kazazian LC, Baramki TA, Thomas RL. 1989. Triploid fetus: An important consideration in the evaluation of very high maternal alpha-fetoprotein. 1989. Prenat Diagn 9: 27-30.
9. Kohn G, Zamir R, Zer T, Amiel A, Fejgin M. 1991. Significance of very low maternal serum human chorionic gonadotropin in prenatal diagnosis of triploidy. Prenat Diagn 11: 277-278.
10. Mason G, Linton G, Cuckle H, Holding S. 1992. Low maternal serum human chorionic gonadotrophin and unconjugated oestriol in a triploidy pregnancy. Prenat Diagn 12: 545-552.
11. McFadden DE, Kalousek DK. 1991. Two different phenotypes of fetuses with chromosomal triploidy: Correlation with parental origin of extra haploid set. Am J Med Genet 38: 535-538.
12. McFadden DE, Kwong LC, Yam IYL, Langlois S. 1993. Parental origin of triploidy in human fetuses: Evidence for genomic imprinting. Hum Genet 92: 465-469.
13. McFadden DE, Lockitch G, Langlois S. 1998. Triple screen in triploidy. Am J Hum Genet 63(Suppl): A168.
14. Oyer CE, Canick Jacob A. 1992. Maternal serum hCG levels in triploidy: Variability and need to consider molar tissue. Prenat Diagn 12: 627-628.
15. Spencer K, Liao AWJ, Skentou H, Cicero S, Nicolaides KH. 2000. Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 20: 495-499.